Table 4.

Cumulated percentage of patients reporting ≥ 3 upper respiratory tract infections and ≥ 3 acute otitis media episodes during the study period

Infection	Month
	1 (%)	2 (%)	3 (%)	4 (%)	5 (%)	6 (%)
URTI
Group A treatment 3 months	0	5	12*	14*	18*	21*
Group B placebo	0	7	22	31	40	52
Group C treatment 6 months	0	6	11*	15*	16*	17*
AOM
Group A treatment 3 months	0	2	6*	13*	19*	21*
Group B placebo	0	4	15	24	36	44
Group C treatment 6 months	0	3	7*	12*	16*	19*

AOM: acute otitis media; URTI: upper respiratory tract infection

* p < 0.05 vs placebo; no other significant differences between the groups